Biotech Stocks

Why Did Atossa Genetics Inc (ATOS) Shares Shoot the Lights Out Today?

Atossa Genetics (NASDAQ:ATOS) is a mover and shaker out on the Street today, with investors …

Sarepta (SRPT): Did You Feel the Ground Shake, Too?

Can you feel the ground moving beneath your feet? Shares of Sarepta (NASDAQ:SRPT) skyrocketed nearly …

Idera Pharmaceuticals (IDRA) Shares Dive on Clinical Setback

Small biotech stocks are often considered “binary” lottery-ticket type events, with either a small chance …

Why Galmed Pharmaceuticals (GLMD) Shares Skyrocketed Over 200% Today

Investors love biotech stocks for the lottery ticket-like returns they can offer if a company …

Maxim Shares Two Cents on Interpace Diagnostics (IDXG) Following Expansion of Reimbursement Contract

Interpace Diagnostics (NASDAQ:IDXG) shares ticked higher today, after the pathology services and molecular diagnostic tests …

Here’s Why Vical (VICL) Shares Took a 30% Plunge Today

Nothing can kill a healthcare’s stock price like a failed clinical trial. Just take a …

Why TapImmune (TPIV) Stock Is Skyrocketing… Again

Shares of the immuno-oncology company soared on news it was raising capital.

Trovagene (TROV): Shoring up the Balance Sheet by Selling Shares Comes with a Price

Shares of molecular diagnostics company TrovaGene (NASDAQ:TROV) are collapsing – down nearly 55% as of …

Here’s Why Axovant Sciences (AXON) Shares Rocketed 115% Today

It’s a very rewarding trading day for investors in Axovant Sciences (NASDAQ:AXON) with shares up …

Are New Drug Approvals Right Around the Corner for Trevena (TRVN) and Array Biopharma (ARRY)?

Analysts chime in across the Street on potential approval odds for TRVN’s pain management drug oliceridine and ARRY’s cancer combination therapy of encorafenib with binimetinib.